Article Text

PDF
Improved outcome of referrals for intestinal transplantation in the UK
  1. Girish L Gupte1,
  2. Susan V Beath1,
  3. Sue Protheroe2,
  4. M Stephen Murphy2,
  5. Paul Davies3,
  6. Khalid Sharif1,
  7. Patrick J McKiernan1,
  8. Jean de Ville de Goyet4,
  9. Ian W Booth5,
  10. Deirdre A Kelly1
  1. 1Liver Unit, Birmingham Children’s Hospital, Birmingham, UK
  2. 2Department of Paediatric Gastroenterology, Birmingham Children’s Hospital, Birmingham, UK
  3. 3Statistical Advisory Service, Birmingham Children’s Hospital, Birmingham, UK
  4. 4Liver Unit, Birmingham Children’s Hospital, Birmingham, UK (1998–2003)
  5. 5Institute of Child Health, Birmingham, UK
  1. Correspondence to:
    Dr G L Gupte
    Consultant Paediatric Hepatologist, Birmingham Children’s Hospital NHS Trust, Steelhouse Lane, Birmingham B4 6NH, UK; girish.gupte{at}bch.nhs.uk

Abstract

Aim: To describe the outcome of children with intestinal failure referred to Birmingham Children’s Hospital (BCH) for consideration of intestinal transplantation (ITx), to determine factors for an adverse outcome and to analyse the impact of post-1998 strategies on survival.

Subjects and methods: A retrospective analysis was performed of children referred for ITx assessment from January 1989 to December 2003. Children were assessed by a multidisciplinary team and categorised into: (a) stable on parenteral nutrition; (b) unsuitable for transplantation (Tx); and (c) recommended for Tx. To analyse the impact of the post-1998 strategies on survival, a comparison was made between the two eras (pre-1998 and post-1998).

Results: 152 children with chronic intestinal failure were identified (63M:89F, median age 10 months (range 1–170)). After assessment, 69 children were considered stable on parenteral nutrition (5-year survival 95%); 28 children were unsuitable for Tx (5-year survival 4%); and 55 children were recommended for Tx (5-year survival 35%, which includes 14 children who died waiting for size-matched organs). Twenty three ITx and nine isolated liver transplants (iLTx) were performed. In a multivariate analysis, the following factors in combination had an adverse effect on survival: the presence of a primary mucosal disorder (p = 0.007, OR ratio 3.16, 95% CI 1.37 to 7.31); absence of involvement of a nutritional care team at the referring hospital (p = 0.001, OR ratio 2.55, 95% CI 1.44 to 4.52); and a serum bilirubin>100 µmol/l (p = 0.001, OR ratio 3.70, 95% CI 1.84 to 7.47). Earlier referral (median serum bilirubin 78 µmol/l in the post-1998 era compared with 237 µmol/l in the pre-1998 era, p = 0.001) may be a contributory factor to improved survival. The strategies of combined en bloc reduced liver/small bowel transplantation and iLTx resulted in fewer deaths on the waiting list in the post-1998 era (2 deaths in post-1998 era v 12 deaths in pre-1998 era). The overall 3-year survival in the post-1998 era (69%) has improved compared with the pre-1998 era (31%; p<0.001)

Conclusion: The changing characteristics at the time of referral, including earlier referral and innovative surgical strategies have resulted in improved long-term survival of children referred for ITx.

  • BCH, Birmingham Children’s Hospital
  • IFALD, intestinal failure associated liver disease
  • SBS, short bowel syndrome

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • Précis
      BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health